Danaher (NYSE:DHR) Price Target Lowered to $325.00 at Benchmark

Danaher (NYSE:DHRGet Rating) had its price target decreased by Benchmark from $345.00 to $325.00 in a research report released on Tuesday morning, The Fly reports. Benchmark currently has a buy rating on the conglomerate’s stock.

A number of other research analysts have also weighed in on DHR. Barclays boosted their target price on Danaher from $290.00 to $310.00 in a report on Friday, July 22nd. UBS Group upped their price objective on Danaher from $297.00 to $323.00 and gave the stock a buy rating in a research report on Thursday, July 28th. Evercore ISI lowered their price objective on Danaher from $320.00 to $280.00 and set an outperform rating for the company in a research report on Tuesday, July 5th. KeyCorp decreased their target price on Danaher from $345.00 to $325.00 and set an overweight rating for the company in a research note on Friday, July 22nd. Finally, Credit Suisse Group assumed coverage on Danaher in a research note on Wednesday, August 24th. They issued an outperform rating and a $340.00 price objective for the company. One equities research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Danaher presently has an average rating of Buy and an average target price of $321.75.

Danaher Price Performance

Shares of DHR opened at $274.37 on Tuesday. Danaher has a twelve month low of $233.71 and a twelve month high of $331.68. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.32 and a current ratio of 1.75. The firm’s 50 day moving average price is $279.85 and its 200 day moving average price is $269.86. The firm has a market cap of $199.59 billion, a PE ratio of 32.32, a PEG ratio of 1.33 and a beta of 0.88.

Danaher (NYSE:DHRGet Rating) last issued its quarterly earnings data on Thursday, July 21st. The conglomerate reported $2.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.35 by $0.41. The company had revenue of $7.75 billion during the quarter, compared to analysts’ expectations of $7.29 billion. Danaher had a return on equity of 18.57% and a net margin of 20.61%. The business’s revenue was up 7.4% on a year-over-year basis. During the same period last year, the business earned $2.46 earnings per share. As a group, research analysts expect that Danaher will post 10.4 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, September 30th will be given a $0.25 dividend. The ex-dividend date is Thursday, September 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.36%. Danaher’s dividend payout ratio (DPR) is currently 11.78%.

Insider Activity at Danaher

In other Danaher news, Director Walter G. Lohr sold 3,906 shares of the stock in a transaction that occurred on Friday, July 22nd. The shares were sold at an average price of $273.84, for a total transaction of $1,069,619.04. Following the sale, the director now directly owns 12,115 shares in the company, valued at approximately $3,317,571.60. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, Director Walter G. Lohr sold 3,906 shares of Danaher stock in a transaction dated Friday, July 22nd. The shares were sold at an average price of $273.84, for a total value of $1,069,619.04. Following the sale, the director now owns 12,115 shares of the company’s stock, valued at $3,317,571.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Joakim Weidemanis sold 12,000 shares of the business’s stock in a transaction dated Monday, July 25th. The stock was sold at an average price of $271.13, for a total transaction of $3,253,560.00. Following the sale, the executive vice president now directly owns 74,398 shares in the company, valued at approximately $20,171,529.74. The disclosure for this sale can be found here. In the last quarter, insiders sold 40,906 shares of company stock valued at $11,823,179. Corporate insiders own 11.20% of the company’s stock.

Institutional Trading of Danaher

Several institutional investors have recently added to or reduced their stakes in DHR. Steward Financial Group LLC increased its holdings in shares of Danaher by 330.4% in the 2nd quarter. Steward Financial Group LLC now owns 99 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 76 shares during the period. GHP Investment Advisors Inc. bought a new position in Danaher during the first quarter valued at approximately $26,000. Lloyd Advisory Services LLC. acquired a new position in Danaher during the first quarter valued at approximately $26,000. Goodman Advisory Group LLC acquired a new position in Danaher during the second quarter valued at approximately $27,000. Finally, Landmark Wealth Management LLC acquired a new stake in shares of Danaher in the first quarter worth $32,000. 77.27% of the stock is owned by institutional investors and hedge funds.

Danaher Company Profile

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Featured Articles

The Fly logo

Analyst Recommendations for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.